MIGLUMIR — PRODUCTIONS FOR BIOPHARMACEUTICAL DEPARTMENT (Q4050672)
Jump to navigation
Jump to search
Project Q4050672 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MIGLUMIR — PRODUCTIONS FOR BIOPHARMACEUTICAL DEPARTMENT |
Project Q4050672 in Italy |
Statements
75,000.0 Euro
0 references
150,000.0 Euro
0 references
50.0 percent
0 references
SERICHIM S.R.L.
0 references
IL PROGETTO HA L¿OBBIETTIVO DI VERIFICARE I PROCESSI DI PRODUZIONE DI TRE PRODOTTI, IL MIGLUSTAT (API), LA TRIPSINA IMMOBILIZZATA, CATALIZZATORE PER LA SINTESI DI DETEMIR E SUCCINIMIDIL MIRISTATO (MIR-OSU), INTERMEDIO AVANZATO PER LA SINTESI DI DETEMIR, A PARTIRE DA TECNOLOGIE DI BASE ACQUISITE (Italian)
0 references
THE PROJECT AIMS TO VERIFY THE PRODUCTION PROCESSES OF THREE PRODUCTS, MIGLUSTAT (API), IMMOBILISED TRYPSIN, CATALYST FOR THE SYNTHESIS OF DETEMIR AND SUCCINIMIDIL MYRISTAT (MIR-OSU), ADVANCED INTERMEDIATE FOR THE SYNTHESIS OF DETEMIR, STARTING FROM ACQUIRED BASIC TECHNOLOGIES (English)
27 January 2022
0 references
LE PROJET VISE À VÉRIFIER LES PROCESSUS DE PRODUCTION DE TROIS PRODUITS, MIGLUSTAT (API), TRYPSINE IMMOBILISÉE, CATALYSEUR POUR LA SYNTHÈSE DU DETEMIR ET SUCCINIMIDIL MYRISTAT (MIR-OSU), INTERMÉDIAIRE AVANCÉ POUR LA SYNTHÈSE DU DETEMIR, À PARTIR DES TECHNOLOGIES DE BASE ACQUISES (French)
28 January 2022
0 references
TORVISCOSA
0 references